<DOC>
	<DOC>NCT00348686</DOC>
	<brief_summary>The purpose of this study is to investigate effect of candesartan based therapy on percent change of B type natriuretic peptides(BNP) level in the subjects with hypertension and left ventricular hypertrophy.</brief_summary>
	<brief_title>Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Hypertrophy, Left Ventricular</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Felodipine</mesh_term>
	<mesh_term>Natriuretic Peptide, Brain</mesh_term>
	<criteria>Hypertension with diastolic blood pressure within 95115 mm/Hg or/and systolic blood pressure within 160200 mm/Hg Patients diagnosed as left ventricular hypertrophy by electrocardiogram Secondary hypertension History of myocardial infarction Stroke within the previous 6 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>LVH</keyword>
</DOC>